Report updated May 31, 2026
myAllergyPal®
For patients currently enrolled in the United Allergy Services immunotherapy protocol and individuals seeking information on allergy testing.
myAllergyPal® is a challenged medical app that is completely free. With a 2.7/5 rating from 158 reviews, it faces significant user friction. Users particularly appreciate allergy tracking features provide helpful reminders for medication schedules when the application functions correctly, though persistent server connectivity errors prevent users from logging injections or accessing their medical data remains a common concern.
What is myAllergyPal®?
myAllergyPal® is a medical tracking app for United Allergy Services patients, providing immunotherapy dosage logs and pollen forecasts on iOS and Android.
Patients hire the app to manage complex immunotherapy schedules, but the current technical failures force them to revert to manual logs, breaking the adherence loop.
Current Momentum
v1.16 · 12mo ago
Zombie- Ships stability-focused updates.
- Last major release May 2025.
Active Nemesis
Fragmented niche
No dominant direct rival identified yet — see Other Rivals below.
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Digital tracking of immunotherapy treatment progress and injection history
Four-day localized pollen level and forecast data
Push notifications for scheduled immunotherapy doses and clinic appointments
How much does it cost?
- Free access to all features
The app operates as a free utility to support the primary business of in-office allergy testing and immunotherapy treatment.
Who Built It?
Enrichment in progress
Publisher profile available very soon
What other apps does United Allergy Services make?
What do users think recently?
Low confidence · Latest 66 of 99 total reviews analyzed · Based on 99 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a frustrated sentiment. Users appreciate allergy tracking features provide helpful reminders for medication schedules when the application functions correctly, but report persistent server connectivity errors prevent users from logging injections or accessing their medical data and inconsistent notification delivery leads to missed medication doses and potential treatment non-compliance for patients.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for myAllergyPal®?
How's The Medical Market?
How does it evolve in the Medical market?
The app holds a #183 position in the Canadian Medical category, reflecting its niche role as a clinical adherence tool rather than a mass-market health app.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇨🇦 Canada | Medical | AndroidFree | #183 | ▼8 |
The rivals identified
Peers
Focuses on gratitude journaling and mood tracking, offering a lighter wellness experience compared to target's clinical medical focus.
Lacks recent development activity, making it a weak competitor compared to target's active medical protocol support.
Includes advanced cognitive distortion tagging features that provide deeper psychological insights than target's basic dosage logging.
Supports PDF export functionality, allowing users to easily share their health progress reports with healthcare providers.
Offers evidence-based CBT tools for anxiety management, whereas target focuses strictly on physical immunotherapy protocols.
Maintains a consistent release cadence with two updates in six months, signaling superior long-term product maintenance.
Poop Tracker- Stool,IBS,Crohns
★3.9 (63)CARECLINIC SOFTWARE INC.
This app competes for the same user demographic seeking to document clinical symptoms and physical health data to share with medical professionals.
Provides specialized clinical data documentation for gastrointestinal health, contrasting with target's focus on allergy-specific immunotherapy logging.
Features a more focused symptom-tracking interface that simplifies the daily logging experience for patients with chronic conditions.
The outtake for myAllergyPal®
Strengths to defend, gaps to attack
Core Strengths
- Proprietary integration with clinical immunotherapy protocols
- Direct B2B distribution channel to existing patients
Critical Frictions
- 2.7★ rating due to server connectivity failures
- High-frequency launch crashes post-update
- Lack of offline data logging capability
Growth Levers
- Implement local data storage for tracking continuity
- Add PDF export for clinical progress sharing
Market Threats
- Manual paper log reversion by patients
- Inconsistent notification delivery causing non-compliance
- Competitor apps offering superior clinical data export
What are the next best moves?
Rebuild server authentication handshake because login failures are the top complaint → restore basic utility
High-frequency server connectivity errors are the primary driver of negative sentiment.
Trade-off: Pause the pollen forecast UI refresh — server stability has 5× the impact on retention.
Ship local data caching because offline access is the top user request → unlock tracking during outages
Users report inability to log doses during network outages, forcing manual paper logs.
Trade-off: Deprioritize the Allergen Library content expansion — data integrity is a higher priority than educational content.
A counter-intuitive read
The app's low rating is actually a signal of high user intent: patients persist in trying to use a broken tool because the clinical protocol requires it.
Feature Gaps vs Competitors
- PDF clinical report export (available in CBT Thought Diary App but absent here)
- Offline-first data logging (available in WorryTree but absent here)
Key Takeaways
The app fails its primary job of clinical adherence due to persistent server instability, so the PM must prioritize local data caching to ensure patients can log doses regardless of connectivity.
Where Is It Heading?
Declining
The medical tracking category is shifting toward offline-first reliability, leaving myAllergyPal® exposed due to its dependency on constant server connectivity. Continued failure to stabilize the login process will accelerate patient churn back to manual documentation, effectively nullifying the app's value as a clinical adherence tool.
Persistent server connectivity failures post-update erode user trust, forcing patients to revert to manual paper logs for their immunotherapy tracking.
Launch crashes following the latest release prevent access to the dosage log, which compounds the existing rating drag on Android.